Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Niche drug maker InnoPharma raises $15 million in private equity

This article was originally published in Scrip

Executive Summary

InnoPharma, a Piscataway, New Jersey-based firm that develops sterile injectable and ophthalmic generics and speciality pharmaceuticals for commercial licensing to pharma partners, has raised $15 million in a series A private financing. The funding was led by the healthcare private equity firm Thomas, McNerney & Partners, two partners of which, Alex Zisson and James Thomas, have joined InnoPharma's board of directors.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel